| | 5051-22-9 Basic information More.. |
| Product Name: | R(+)-propranolol HCl | | Synonyms: | (+)-2-propano;(+)-propranolol;(r)-2-propano;(2R)-1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol;(2R)-1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;R(+)-PROPRANOLOL HYDROCHLORIDE >98%;2-Propanol, 1-(isopropylamino)-3-(1-naphthyloxy)-, (+)- (8CI);2-Propanol, 1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)-, (2R)- (9CI) | | CAS: | 5051-22-9 | | MF: | C16H21NO2 | | MW: | 259.34 | | EINECS: | 225-749-2 | | Mol File: | 5051-22-9.mol |  |
Use
R(+)-PROPRANOLOL HCL(Inderal, others) is the prototypical andnonselective β-blocker. It blocks the β1- and β2-receptorswith equal affinity, lacks ISA, and does not block β-receptors. R(+)-PROPRANOLOL HCL like the other β-blockers discussed,is a competitive blocker whose receptor-blockingactions can be reversed with sufficient concentrations of β-agonists.
Currently, R(+)-PROPRANOLOL HCL is approved for use inthe United States for hypertension, cardiac arrhythmias,angina pectoris, postmyocardial infarction, hypertrophiccardiomyopathy, pheochromocytoma, migraine prophylaxis,and essential tremor. In addition, because of its highlipophilicity (log P=3.10) and thus its ability to penetratethe CNS, propranolol has found use in treating anxiety andis under investigation for the treatment of a variety of otherconditions, including schizophrenia, alcohol withdrawalsyndrome, and aggressive behavior.
- R(+)-PROPRANOLOL HCL
-
- $7.00
- 2020-01-10
- CAS:5051-22-9
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100KG
|
|
5051-22-9
Recommend
Suppliers |
|
|
Recommend You Select Member Companies |
|
|